13 September 2011
A protein synthesised by muscles known as cardiotrophin 1 has been found to increase the rate at which fat is burned in muscles.
The discovery from scientists based at the Center for Applied Medical Research in the US and the University of Navarra in Spain could potentially have ramifications for people suffering from obesity who sometimes opt for some form of weight loss surgery instead.
Pablo Ortiz, chief executive officer of Digna Biotech, the firm which produces the drug, said: "Cardiotrophin 1 showed a very interesting effect on fat metabolism which deserves to be explored in a clinical setting."
The protein has also been shown as a beneficial drug from use in liver transplantation and has consequently been granted orphan drug status by the US Food and Drug Administration and European Medicines Agency.
However, registered nutritionist Dr Carina Norris reiterated in previous comments the importance of a balanced diet in losing and controlling weight as many people, even when attempting to lose weight, often neglect certain food groups in a bid to reduce body fat rapidly.
Posted by Jeanette Royston
1 Moreno-Aliaga, María J., et. al., "Cardiotrophin-1 Is a Key Regulator of Glucose and Lipid Metabolism". Cell Metabolism. August 3rd 2011.
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.